• About us
• Contact

Advertisement

Organisation › Details

Verily Life Sciences LLC

Verily is a life sciences research and engineering organization focused on improving healthcare outcomes by applying the latest scientific and technological advances to significant problems in health and biology. By combining unparalleled capabilities in data organization and analytics services with robust scientific and product engineering expertise, Verily is targeting the dual objectives of creating tools and user-friendly platforms that capture a deeper and broader set of health data and organizing the data so that it is useful and actionable. Verily partners with leading life sciences, medical device and government organizations to leverage deep domain expertise and resources that enable exponentially faster development, meaningful advancements and deployment at scale. *

 

	Start	2016-08-01 renamed before
	Group	Alphabet (formerly Google) (Group)
	Predecessor	Google Life Sciences LLC
	Industry	healthcare informatics
	Industry 2	LIFE SCIENCES
	Person	Conrad, Andrew (Alphabet 201608 CEO of Verily Life Sciences)
	Region	Mountain View, CA
	Country	United States (USA)
	City	n. a.
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA.
		Record changed: 2021-08-14

Advertisement

More documents for Alphabet (formerly Google) (Group)

• [1] BenevolentAI. (9/18/23). "Press Release: BenevolentAI Welcomes Christina Busmalis as Its New Chief Revenue Officer". London....
• [2] Bayer AG. (1/11/23). "Press Release: Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power". Berlin & Sunnyvale, CA....
• [3] Isopmorphic Labs Ltd.. (5/12/22). "Press Release: Isomorphic Labs Announces First Phase of Management Team". London....
• [4] Isopmorphic Labs Ltd.. (11/4/21). "Blog Post: Introducing Isomorphic Labs"....
• [5] EMBL. (7/22/21). "Press Release: DeepMind and EMBL Release the Most Complete Database of Predicted 3D Structures of Human Proteins". London....
• [6] Hologic, Inc.. (2/1/21). "Press Release: Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities". Marlborough, MA....
• [7] Boehringer Ingelheim. (1/11/21). "Press Release: Quantum Computing. Boehringer Ingelheim and Google Partner for Pharma R&D". Ingelheim & Mountain View, CA....
• [8] Verily Life Sciences. (12/17/20). "Press Release: Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms". South San Francisco, CA....
• [9] Spotlight Therapeutics, Inc.. (11/30/20). "Press Release: Spotlight Therapeutics Closes $30M Series A Led by GV to Advance Pipeline of Non-viral CRISPR Gene Editing Biologics". San Francisco, CA....
• [10] Cerevance. (4/14/20). "Press Release: Cerevance Closes $45 Million Series B Financing". Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.